Advertisement

Contrast media

  • E. Schouman-Claeys
  • G. Frija

Abstract

Tissues contrast in magnetic resonance imaging (MRI) is dependant primarily upon the relaxation times T1 and T2, proton density, and blood flow. Signal differences between various structures are usually enhanced by appropriately altering MR pulse sequences in order to visualize the effects of these parameters. In order to improve this capacity for tissue differentiation, and therefore the sensitivity of MRI, the use of MRI tracers to mark normal or pathological tissue has been proposed.

Keywords

Proton Relaxation Paramagnetic Substance Magnetic Momentum Paramagnetic Contrast Medium Magnetic Resonance Imaging Contrast Medium 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Allard M, Kien P, Doucet D, Caille JM (1987) Neurotoxicity of magnetic resonance contrast media (communication). Society of Magnetic Resonance in medicine, New York: 934Google Scholar
  2. 2.
    Bacic GG, Niesman MR, Magin RL, Wright SM, Swartz HM (1987) The use of Dextran Magnetite for liver contrast enhancement (communication). Society of Magnetic Resonance in medicine, New York: 328Google Scholar
  3. 3.
    Berry I, Brant-Zawaszki M, Osaki L, Brasch R, Murovic J, Newton TH (1986) Gd-DTPA in clinical MR of the brain: 2. Extraaxial lesions and normal structures. AJNR 7: 789–793Google Scholar
  4. 4.
    Bloem JL, Bluemm RG, Taminiau AH, Doornbos J (1987) Gd-DTPA enhanced MRI of primary malignant bone tumors. Society of Magnetic Resonance in medicine, New York: 6675.Google Scholar
  5. 5.
    Bloembergen N, Morgan L (1961) Proton relaxation times in paramagnetic solutions. Effects of electron spin relaxation. J Chem Phys 34: 842–850CrossRefGoogle Scholar
  6. 6.
    Bonnemain B, Lautrou J, Meyer D, Doucet D (1987) Produits de contraste non radiologiques (IRM). In: Amiel M, Ducassou D, Frija G, Grenier PH (eds) Recherche en imagerie médicale. Colloque INSERM 160: 61–76Google Scholar
  7. 7.
    Bousquet JC, Doucet D, Bonnemain B, Saini S, Ferrucci JT (1986) Hepatic Pharmacokinetics of Gd-DOTA in liver MR (communication). Society of Magnetic Resonance in medicine, Montréal: 1533–1534Google Scholar
  8. 8.
    Bousquet JC, Saini S, Stark DD, Bonnemain B, Doucet D, Hahn PF, Weissleder R, Rummeny E, Wittenberg J, Ferrucci JT (1987) Comparison of the relaxivity, pharmacokinetics and toxicity of Gd-DTPA and Gd-DOTA (communication). Society of Magnetic Resonance in medicine, New York: 661Google Scholar
  9. 9.
    Brant-Zawadsky M, Berry I, Osaki L, Brasch R, Murovic J, Norman D (1986) Gd-DTPA in clinical MR of the brain 1. Intraaxial lesions. AJNR 7: 781–788Google Scholar
  10. 10.
    Brasch RC, Weinmann HJ, Wesbey GE (1984) Contrastenhanced NMR Imaging: animal studies using Gadolinium DTPA complex. AJR 142: 625–630PubMedGoogle Scholar
  11. 11.
    Breger RK, Papke RA, Pojunas KW, Haughton VM, Williams AL, Daniels PL (1987) Benign extra-axial tumors: contrast enhancement with Gd-DTPA. Radiology 163: 427–429PubMedGoogle Scholar
  12. 12.
    Caride VJ, Sostman HD, Winchell RJ, Gore JC (1984) Relaxation enhancement using liposomes carrying paramagnetic species. Magn Reson Imag 2: 107–112CrossRefGoogle Scholar
  13. 13.
    Carr DH, Brown J, Bydder GM, Steiner RE, Weinmann JH, Speck U, Hall AS, Young IR (1984) Gadolinium-DTPA as a contrast agent in MRI: initial clinical experience in 20 patients. AJR 143: 215–224PubMedGoogle Scholar
  14. 14.
    Carr DH, Gadian DG (1985) Contrast agents in Magnetic Resonance Imaging. Clin Radiol 36: 561–568PubMedCrossRefGoogle Scholar
  15. 15.
    Carvlin M, Renshaw PF, Dougherty L, Kassab E, Moore B, Arger P, Joseph FM, Axel L, Kundel H (1987) Superparamagnetic particles: demonstration of renal perfusion and vasculature by Dextran-Magnetite (communication). Society of Magnetic Resonance in medicine, New York: 663Google Scholar
  16. 16.
    Claussen C, Laniado M, Schörner W, Niendorf HP, Weinmann HJ, Fiegler W, Felix R (1985) Gadolinium-DTPA in MR Imaging of glioblastomas and intracranial metastases. AJNR 6: 669–674PubMedGoogle Scholar
  17. 17.
    Conger RL, Selwood PW (1952) Proton relaxation in paramagnetic solutions. J Chem Phys 20: 383–387CrossRefGoogle Scholar
  18. 18.
    Davis PC, Hoffman JC Jr, Malko JA, Tindall GT, Takei Y, Avruch L, Braun IF (1987) Gadolinium-DTPA an MR Imaging of pituitary adenoma: a preliminary report. AJNR 8: 817–823PubMedGoogle Scholar
  19. 19.
    Les produits de contraste en Imagerie par Résonance Magnétique (1985). In: J de Certaines (ed)Google Scholar
  20. 20.
    Desreux JF (1980) Nuclear Magnetic Resonance spectroscopy of lanthanide complexes with a tetraacetic tetraaza macrocycle. Unusual conformation properties. Inorg Chem 19 (5): 1319–1324CrossRefGoogle Scholar
  21. 21.
    Doucet D, Juge M, Brelet F, Josipowicz N, Bonnemain B (1987) Study of a new MRI contrast agent, Gd-DOTA, in rats with induced brain edema (communication). Society of Magnetic Resonance in medicine, New York: 249Google Scholar
  22. 22.
    Dwyer AJ, Frank JA, Doppman JL, Osfield EH, Hickey AM, Cutler GB, Loriaux DL, Shiable TF (1987) Pituitary adenomas in patients with cushing disease: initial clinical experience with Gd-DTPA-enhanced MR imaging. Radiology 163: 421–426PubMedGoogle Scholar
  23. 23.
    Felix R, Schörner W, Laniado M, Niendorf HP, Claussen C, Fiegler W, Speck U (1985) Brain tumors: MR Imaging with Gadolinium-DTPA. Radiology 156: 681–688PubMedGoogle Scholar
  24. 24.
    Gadian DG, Payne JA, Bryant DJ, Young IR, Can DH, Bydder GM (1985) Gadolinium-DTPA as a contrast agent in MR imaging. Theoretical projections and practical observations. J Comput Assist Tomogr 9: 242–251PubMedCrossRefGoogle Scholar
  25. 25.
    Geraldes CF, Sherry AD, Brown RD, Koenig SH (1986) Magnetic field dependence of solvent proton relaxation rates induced by Gd3+ and Mn2 complexes of various polyaza macrocyclic ligands: implications for NMR Imaging. Magn Reson Med 3: 242–250PubMedCrossRefGoogle Scholar
  26. 26.
    Graif M, Bydder GM, Steiner RE, Niendorf P, Thomas DGT, Young IR (1985) Contrast-enhanced imaging of malignant brain tumors. AJNR 6: 855–862PubMedGoogle Scholar
  27. 27.
    Greif WL, Buxton RB, Lauffer RB, Saini S, Stark DD, Wedeen VJ, Rosen BR, Brady TJ (1985) Pulse sequence optimization for MR Imaging using a paramagnetic hepatobiliary contrast agent. Radiology 157: 461–466PubMedGoogle Scholar
  28. 28.
    Greselle JF (1987) Les complexes du Gadolinium en imagerie par résonance magnétique. Analyse de 63 observations. Thèse de médecine, BordeauxGoogle Scholar
  29. 29.
    Grossman RI, Gonzales-Scarano F, Atlas SW, Galetta S, Silberberg DH (1986) Multiple sclerosis: Gadolinium enhancement in MR Imaging. Radiology 161: 721–725PubMedGoogle Scholar
  30. 30.
    Hemmingsson A, Ericsson A, Jung B, Lonnemark M, Sperber GO, Carlsten J (1987) Effects of magnetic particles in magnetic resonance imaging (communication). Society of Magnetic Resonance in medicine, New York: 666Google Scholar
  31. 31.
    Jenkins JP, Stack JP, Watson Y, Isherwood I (1987) Magnetic Resonance Imaging of spinal lesions: the role of Gadolinium DTPA (communication). Society of Magnetic Resonance in medicine, New York: 8Google Scholar
  32. 32.
    Josipowicz N, Bonnemain B, Caille JM, Meyer D (1985) Etude pharmacocinétique du DTPA-Gd et du DOTA-Gd chez le lapin (communication). Journées françaises de Radiologie, Paris 1985. J Radiol 66: 748Google Scholar
  33. 33.
    Knop RH, Frank JA, Dwyer AJ, Girton M, Naegele M, Schrader M, Cobb J, Gansow 0, Maegerstadt M, Brechbiel M, Baltzer L, Doppman JL (1987) Gadolinium cryptelates as MR contrast agents. J Comput Assist Tomogr 11: 35–42PubMedCrossRefGoogle Scholar
  34. 34.
    Koenig SH (1985) Magnetic field dependence of proton relaxation rates in tissue with added Mn2+: rabbit liver and kidney. Magn Reson Med 2: 159–168PubMedCrossRefGoogle Scholar
  35. 35.
    Koenig SH, Baglin C, Brown III RD (1984) Magnetic field dependence of solvent proton relaxation induced by Gd3+ and Mn2+ complexes. Magn Reson Med 1: 496–501PubMedCrossRefGoogle Scholar
  36. 36.
    Koenig SH, Brown III RD (1984) Relaxation of solvent protons by paramagnetic ions and its dependence on magnetic field and chemical environment: implications for NMR imaging. Magn Reson Med 1: 478–495PubMedCrossRefGoogle Scholar
  37. 37.
    Laniado M, Kaminsky S, Weinmann HJ, Claussen C (1987) Positive and negative MR-contrast media for gastrointestinal contrast enhancement: an experimental study (communication). Society of Magnetic Resonance in medicine, New York: 330Google Scholar
  38. 38.
    Lhoste JM (1983) Principles and practical aspects of contrast agents for NMR Imaging. Ann Ist Super Sanita 19: 155–160PubMedGoogle Scholar
  39. 39.
    McNamara MT (1987) Paramagnetic contrast media for magnetic resonance imaging of the central nervous system. In: McNamara MT (ed) Magnetic Resonance Imaging of the Central Nervous System. Raven Press 6: 97–105Google Scholar
  40. 40.
    McNamara MT, Brant-Zawadazki M, Berry I, Pereira B, Weinstein P, Derugin N, Moore S, Kucharczyk W, Brasch RC (1986) Acute experimental cerebral ischemia: MR enhancement using Gd-DTPA. Radiology 158: 701–705PubMedGoogle Scholar
  41. 41.
    McNamara MT, Higgins CB, Ehman RL, Revel D, Sievers R, Brasch RC (1984) Acute myocardial ischemia: magnetic resonance contrast enhancement with Gadolinium-DTPA. Radiology 153: 157–163PubMedGoogle Scholar
  42. 42.
    McNamara MT, Tscholakoff D, Revel D, Soulen R, Schechtmann N, Botvinick E, Higgins CB (1986) Differentiation of reversible and irreversible myocardial injury by MR Imaging with and without Gadolinium-DTPA. Radiology 158: 765–769PubMedGoogle Scholar
  43. 43.
    McNamara MT, Wesbey GE, Brasch RC, Sievers R, Lipton MJ, Higgins CB (1985) Magnetic Resonance Imaging of acute myocardial infarction using a nitroxyl spin label (PCA). Invest Radiol 20: 591–595PubMedCrossRefGoogle Scholar
  44. 44.
    Magerstädt M, Gansow OA, Brechbiel MW, Colcher D, Baltzer L, Knop RH, Girton ME, Naegele M (1986) Gd(DOTA): an alternative to Gd(DTPA) as a T1,2 relaxation agent for NMR Imaging of spectroscopy. Magn Reson Med 3: 808–812PubMedCrossRefGoogle Scholar
  45. 45.
    Mano I, Yoshida H, Nakabayashi K, Yashiro N, Lio M (1987) Fast spin echo imaging with suspended respiration: Gadolinium enhanced MR Imaging of liver tumors. J Comput Assist Tomogr 11: 73–80PubMedCrossRefGoogle Scholar
  46. 46.
    Mattrey RF, Hajek PC, Gylys-Morin VM, Martin J, Long DC, Long DM (1987) Perfluorochemicals as gastrointestinal contrast agents for MR imaging: preliminary studies in rats and humans. AJR 148: 1259–1263PubMedGoogle Scholar
  47. 47.
    Mendonca Dias MH, Lauterbur PC (1986) Ferromagnetic particles as contrast agents for magnetic resonance imaging of liver and spleen. Magn Reson Med 3: 328–330PubMedCrossRefGoogle Scholar
  48. 48.
    Miller DH, Rudge P, McManus DG, Johnson G, Barnes D, McDonald WI (1987) Serial MRI studies with Gadolinium DTPA in acute relapsing multiple sclerosis (communication). Society of Magnetic Resonance in medicine, New York: 42Google Scholar
  49. 49.
    Niendorf HP, Laniado M, Semmler W, Schorner W, Felix R (1987) Dose administration of Gadolinium-DTPA in MR Imaging of intracranial tumors. AJNR 8: 803–815PubMedGoogle Scholar
  50. 50.
    Pople JA, Schneider WG, Bernstein HJ (1959) Highresolution nuclear magnetic resonance. McGraw-Hill, New York, p 209Google Scholar
  51. 51.
    Renshaw PF, Owen CS, McLaughlin AC, Frey TG, Leigh JS Jr (1986) Ferromagnetic contrast agents: a new approach. Magn Reson Med 3: 217–225PubMedCrossRefGoogle Scholar
  52. 52.
    Runge VM, Clanton JA, Foster MA, Smith FW, Lukehart CM, Jones MM, Partain CL, James AE Jr (1984) Paramagnetic NMR contrast agents; development and evaluation. Invest Radiol 19: 408–415PubMedCrossRefGoogle Scholar
  53. 53.
    Runge VM, Clanton JA, Herzer WA, Gibbs SJ, Price AC, Partain CL, James AE Jr (1984) Intravascular contrast agents suitable for Magnetic Resonance Imaging. Radiology 153: 171–176PubMedGoogle Scholar
  54. 54.
    Runge VM, Clanton JA, Lukehart CM, Partain CL, James AE Jr (1983) Paramagnetic agents for contrast-enhanced NMR imaging: a review. AJR 141: 1209–1215PubMedGoogle Scholar
  55. 55.
    Runge VM, Clanton JA, Price AC, Wehr CJ, Herzer WA, Partain CL, James AE Jr (1985) The use of Gd-DTPA as a perfusion agent and marker of blood-brain barrier disruption. Magn Reson Imag: 43–55Google Scholar
  56. 56.
    Runge VM, Price AC, Wehr CJ, Atkinson JB, Tweedle MF (1985) Contrast enhanced MRI: evaluation of a canine model of osmotic blood-brain barrier disruption. Invest Radiol 20: 830–844PubMedCrossRefGoogle Scholar
  57. 57.
    Runge VM, Clanton JA, Wehr CJ, Partain CL, James AE Jr (1985) Gated magnetic resonance imaging of acute myocardial ischemia in dogs: application of multiecho techniques and contrast enhancement with Gd-DTPA. Magn Reson Imag 3: 255–266CrossRefGoogle Scholar
  58. 58.
    Saini S, Stark DD, Brady TJ, Wittenberg J, Ferrucci JT Jr (1986) Dynamic spin-echo MRI of liver cancer using Gadolinium-DTPA: animal investigation. AJR 147: 357–362PubMedGoogle Scholar
  59. 59.
    Saini S, Weissleder R, Rummeny E, Stark DD, Hahn PF, Mueller PR, Steiner E, Simeone JF, Wittenberg J, Ferrucci JT (1987) Gd-DOTA: Dose analysis for liver imaging (communication). Society of Magnetic Resonance in medicine, New York: 662Google Scholar
  60. 60.
    Schmiedl U, Ogan MD, Moseley ME, Brasch RC (1986) Comparison of the contrast-enhancing properties of Albumin(Gd-DTPA) and Gd-DTPA at 2.0 T: an experimental study in rats. AJR 147: 1263–1270PubMedGoogle Scholar
  61. 61.
    Schmiedl U, Moseley ME, Ogan MD, Chew WM, Brasch RC (1987) Comparison of initial biodistribution patterns of Gd-DTPA and Albumin-(Gd-DTPA) using rapid spin echo MR Imaging. J Comput Assist Tomogr 11: 306–313PubMedCrossRefGoogle Scholar
  62. 62.
    Schörner W, Laniado M, Niendorf HP, Schubert C, Felix R (1986) Time-dependent changes in image contrast in brain tumors after Gadolinium-DTPA. AJNR 7: 1013–1020PubMedGoogle Scholar
  63. 63.
    Shtern F, Garrido L, Compton C, Swiniarski JK, Buxton RB, Lauffer RB, Brady TJ (1987) MR Imaging of liver tumors in mice: contrast enhancement with Fe (EHPG) (communication). Society of Magnetic Resonance in medicine, New York: 175Google Scholar
  64. 64.
    Slasky BS, Byde GM, Niendorf HP, Young IR (1987) MR Imaging with Gadolinium-DTPA in the differentiation of tumor, syrinx, and cyst of the spinal cord. J Comput Assist Tomogr 11: 845–850PubMedCrossRefGoogle Scholar
  65. 65.
    Slutsky RA, Peterson T, Strich G, Brown JJ (1985) Hemodynamic effects of rapid and slow infusions of Manganese Chloride and Gadolinium-DTPA in dogs. Radiology 154: 733–735PubMedGoogle Scholar
  66. 66.
    Strich G, Hagan PL, Gerber KH, Slutsky RA (1985) Distribution and magnetic resonance spin lattice relaxation effects of Gadolinium-DTPA. Radiology 154: 723–726PubMedGoogle Scholar
  67. 67.
    Sze G, Abamson A, Krol G, Liu D, Amster J, Zimmerman R, Deck MD (1987) Gadolinium-DTPA in the evaluation of leptomeningeal tumor spread in the spine (communication). Society of Magnetic Resonance in medicine, New York: 6Google Scholar
  68. 68.
    Tsang YM, Stark DD, Chen MC, Wittenberg JK, Ferrucci JT (1987) MR detection of hepatic micrometastases: animal investigation using ferrite particles (communication). Society of Magnetic Resonance in medicine, New York: 177Google Scholar
  69. 69.
    Tscholakoff D, Higging CB, Sechtem U, McNamara MT. (1986) Occlusive and reperfused myocardial infarcts: effect of Gd-DTPA on ECG-gated MR Imaging. Radiology 160: 515–519PubMedGoogle Scholar
  70. 70.
    Tweedle MF, Hagan JJ, Dose EV, Mantha S, Cicero S (1987) Reaction of Gd Complexes with endogenously available ions (communication). Society of Magnetic Resonance in medicine, New York: 477Google Scholar
  71. 71.
    Unger EC, Toptty WG, Neufeld DM, Otsuka FL, Murphy WA, Welch MS, Connett JM, Philpott GW (1985) Magnetic Resonance Imaging using Gadolinium labeled monoclonal antibody. Invest Radiol 20: 693–700PubMedCrossRefGoogle Scholar
  72. 72.
    Weinmann HJ, Brasch RC, Press WR, Wesbey GE (1984) Characteristics of Gadolinium-DTPA complex: a potential NMR contrast agent. AJR 142: 619–624PubMedGoogle Scholar
  73. 73.
    Wesbey GE, Brasch RC, Engelstad BL, Moss AA, Crooks LE, Brito AC (1983) Nuclear Magnetic Resonance contrast enhancement study of the gastrointestinal tract of rats and a human volunteer using nontoxic oral iron solutions. Radiology 149: 175–180PubMedGoogle Scholar
  74. 74.
    Wesbey GE, Higgins CB, McNamara MT, Engelstad BL, Lipton MJ, Sievers R, Ehman RL, Lovin J, Brasch RC (1984) Effect of Gadolinium-DTPA on the magnetic relaxation times of normal and infarcted myocardium. Radiology 153: 165–169PubMedGoogle Scholar
  75. 75.
    Widder DJ, Edelman RR, Grief WL, Monda L (1987) Magnetite albumin supension: a superparamagnetic oral MR contrast agent. AJR 149: 839–843PubMedGoogle Scholar
  76. 76.
    Widder DJ, Greif WL, Widder KJ, Edelman RR, Brady TJ (1987) Magnetite albumin microspheres: a new MR contrast material. AJR 148: 399–404PubMedGoogle Scholar
  77. 77.
    Wolf GL, Baum L (1983) Cardiovascular toxicity and tissue proton T1 response to Manganese injection in the dog and rabbit. AJR 141: 193–197PubMedGoogle Scholar
  78. 78.
    Wolf GL, Fobben ES (1984) The tissue Proton T1 and T2 response to Gadolinium-DTPA injection in rabbits. A potential renal contrast agent for NMR Imaging. Invest Radiol 19: 324–328PubMedCrossRefGoogle Scholar
  79. 79.
    Wolf GL, Joseph PM, Goldstein EJ. Optimal pulsing sequences for MR contrast agents. AJR 147: 367–371Google Scholar
  80. 80.
    Worah D, Burnett K, Kanal E, Wolf G, Quay SC (1987) Preclinical and clinical studies with ferrioxamine as a Magnetic Resonance contrast agent (communication). Society of Magnetic Resonance in medicine, New York:17Google Scholar
  81. 81.
    Young IR, Clarke GJ, Bailes DR, Pennock JM, Doyle FH, Bydder GM (1982) Enhancement of relaxation rate with paramagnetic contrast agents in NMR Imaging. J Comput Assist Tomogr 6: 1–18PubMedCrossRefGoogle Scholar
  82. 82.
    Yousry T, Fink U, Tiling R, Wirth CJ, Bohm P, Lissner J (1987) The role of Gd-DTPA in improving the MR diagnosis of bone and soft tissue tumors (communication). Society of Magnetic Resonance in medicine, New York: 15Google Scholar

Copyright information

© Springer-Verlag France 1989

Authors and Affiliations

  • E. Schouman-Claeys
  • G. Frija

There are no affiliations available

Personalised recommendations